18.01
price up icon0.06%   0.01
after-market Handel nachbörslich: 18.01
loading
Schlusskurs vom Vortag:
$18.00
Offen:
$17.98
24-Stunden-Volumen:
1.12M
Relative Volume:
2.90
Marktkapitalisierung:
$792.59M
Einnahmen:
$159.01M
Nettoeinkommen (Verlust:
$-21.72M
KGV:
-34.63
EPS:
-0.52
Netto-Cashflow:
$-20.63M
1W Leistung:
-0.66%
1M Leistung:
-0.72%
6M Leistung:
+43.85%
1J Leistung:
+73.67%
1-Tages-Spanne:
Value
$17.10
$18.61
1-Wochen-Bereich:
Value
$17.10
$19.19
52-Wochen-Spanne:
Value
$5.55
$19.19

Axogen Inc Stock (AXGN) Company Profile

Name
Firmenname
Axogen Inc
Name
Telefon
(386) 462-6817
Name
Adresse
13631 PROGRESS BLVD., ALACHUA, FL
Name
Mitarbeiter
428
Name
Twitter
@AxoGen
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
AXGN's Discussions on Twitter

Vergleichen Sie AXGN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
AXGN
Axogen Inc
18.01 792.59M 159.01M -21.72M -20.63M -0.52
Medical Devices icon
ABT
Abbott Laboratories
134.95 234.06B 41.95B 13.40B 6.49B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
104.39 154.06B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
387.92 148.02B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
90.17 115.71B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
72.76 42.91B 5.72B 4.17B 490.10M 6.97

Axogen Inc Stock (AXGN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-07-01 Eingeleitet Raymond James Outperform
2022-11-11 Fortgesetzt Jefferies Buy
2022-05-09 Hochstufung Canaccord Genuity Hold → Buy
2022-03-11 Fortgesetzt Cantor Fitzgerald Overweight
2020-10-23 Eingeleitet Guggenheim Buy
2020-06-16 Fortgesetzt Cantor Fitzgerald Overweight
2020-05-07 Herabstufung Canaccord Genuity Buy → Hold
2020-04-02 Herabstufung BTIG Research Buy → Neutral
2019-08-07 Herabstufung William Blair Outperform → Mkt Perform
2019-07-12 Eingeleitet Canaccord Genuity Buy
2018-03-02 Bestätigt Lake Street Buy
2018-01-05 Fortgesetzt Cantor Fitzgerald Overweight
2017-11-30 Eingeleitet Jefferies Buy
2017-11-21 Bestätigt Lake Street Buy
2017-07-31 Eingeleitet Leerink Partners Outperform
2017-06-30 Eingeleitet Cantor Fitzgerald Overweight
2017-03-06 Eingeleitet ROTH Capital Buy
2016-11-22 Hochstufung Lake Street Hold → Buy
2016-11-07 Bestätigt Wedbush Outperform
2016-11-03 Herabstufung Lake Street Buy → Hold
2016-08-04 Bestätigt Wedbush Outperform
2014-05-14 Eingeleitet Dawson James Buy
2013-10-31 Bestätigt Ladenburg Thalmann Buy
Alle ansehen

Axogen Inc Aktie (AXGN) Neueste Nachrichten

pulisher
01:57 AM

AxoGen Q4 2024 Earnings Preview - MSN

01:57 AM
pulisher
Feb 21, 2025

AxoGen (AXGN) Expected to Announce Earnings on Tuesday - Defense World

Feb 21, 2025
pulisher
Feb 15, 2025

Objective long/short (AXGN) Report - Stock Traders Daily

Feb 15, 2025
pulisher
Feb 11, 2025

Axogen, Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025 - Nasdaq

Feb 11, 2025
pulisher
Feb 11, 2025

Axogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025 - GlobeNewswire

Feb 11, 2025
pulisher
Feb 11, 2025

Axogen's Pivotal Earnings Reveal: Q4 & 2024 Performance Deep Dive Coming Soon - StockTitan

Feb 11, 2025
pulisher
Feb 11, 2025

AxoGen (NASDAQ:AXGN) Hits New 52-Week HighHere's Why - MarketBeat

Feb 11, 2025
pulisher
Feb 09, 2025

Calamos Advisors LLC Makes New $523,000 Investment in AxoGen, Inc. (NASDAQ:AXGN) - MarketBeat

Feb 09, 2025
pulisher
Feb 08, 2025

Canaccord raises AxoGen stock price target to $22 from $18 By Investing.com - Investing.com Nigeria

Feb 08, 2025
pulisher
Feb 07, 2025

AxoGen (NASDAQ:AXGN) Price Target Raised to $22.00 - MarketBeat

Feb 07, 2025
pulisher
Feb 05, 2025

Short Interest in AxoGen, Inc. (NASDAQ:AXGN) Increases By 20.4% - MarketBeat

Feb 05, 2025
pulisher
Feb 04, 2025

Axogen appoints new VP of Regulatory Affairs - MSN

Feb 04, 2025
pulisher
Feb 04, 2025

PepsiCo Reports Mixed Financial Results - The Globe and Mail

Feb 04, 2025
pulisher
Feb 04, 2025

AxoGen, Inc. (NASDAQ:AXGN) Shares Acquired by SG Americas Securities LLC - Defense World

Feb 04, 2025
pulisher
Feb 04, 2025

AxoGen (NASDAQ:AXGN) Price Target Raised to $22.00 at Canaccord Genuity Group - Defense World

Feb 04, 2025
pulisher
Feb 03, 2025

Morgan Stanley Reduces Stake in Axogen Inc: A Detailed Analysis - GuruFocus.com

Feb 03, 2025
pulisher
Feb 03, 2025

Axogen Announces Appointment of Jesse Bishop as Vice - GlobeNewswire

Feb 03, 2025
pulisher
Feb 03, 2025

Canaccord raises AxoGen stock price target to $22 from $18 - MSN

Feb 03, 2025
pulisher
Feb 03, 2025

AxoGen appoints Jesse Bishop as VP, regulatory affairs - TipRanks

Feb 03, 2025
pulisher
Feb 03, 2025

Axogen Announces Appointment of Jesse Bishop as Vice President of Regulatory Affairs and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Feb 03, 2025
pulisher
Feb 03, 2025

From Army Ranger to Biotech Executive: Special Ops Veteran Takes Helm of Axogen's Regulatory Strategy - StockTitan

Feb 03, 2025
pulisher
Jan 25, 2025

Axogen stock soars to 52-week high, touches $18.99 - MSN

Jan 25, 2025
pulisher
Jan 25, 2025

Cantor Fitzgerald Lowers Earnings Estimates for AxoGen - ETF Daily News

Jan 25, 2025
pulisher
Jan 24, 2025

Trend Tracker for (AXGN) - Stock Traders Daily

Jan 24, 2025
pulisher
Jan 24, 2025

Cantor Fitzgerald Weighs in on AxoGen FY2024 Earnings - Defense World

Jan 24, 2025
pulisher
Jan 23, 2025

FY2024 EPS Estimates for AxoGen Lowered by Cantor Fitzgerald - MarketBeat

Jan 23, 2025
pulisher
Jan 23, 2025

AxoGen (NASDAQ:AXGN) Reaches New 1-Year HighHere's Why - MarketBeat

Jan 23, 2025
pulisher
Jan 22, 2025

Axogen stock soars to 52-week high, touches $18.99 By Investing.com - Investing.com Australia

Jan 22, 2025
pulisher
Jan 19, 2025

AxoGen (NASDAQ:AXGN) Reaches New 1-Year High – Time to Buy? - Defense World

Jan 19, 2025
pulisher
Jan 19, 2025

Axogen (FRA:LT3) Earnings Yield % : N/A% (As of Jan. 19, 2025) - GuruFocus.com

Jan 19, 2025
pulisher
Jan 18, 2025

Axogen (FRA:LT3) 5-Year Yield-on-Cost % : 0.00 (As of Jan. 18, 2025) - GuruFocus.com

Jan 18, 2025
pulisher
Jan 18, 2025

Assenagon Asset Management S.A. Sells 484,570 Shares of AxoGen, Inc. (NASDAQ:AXGN) - MarketBeat

Jan 18, 2025
pulisher
Jan 17, 2025

AxoGen (NASDAQ:AXGN) Reaches New 12-Month HighShould You Buy? - MarketBeat

Jan 17, 2025
pulisher
Jan 16, 2025

AxoGen (AXGN) Moves 18.2% Higher: Will This Strength Last? - MSN

Jan 16, 2025
pulisher
Jan 15, 2025

AxoGen, Inc. (NASDAQ:AXGN) Shares Bought by JPMorgan Chase & Co. - Defense World

Jan 15, 2025
pulisher
Jan 15, 2025

JPMorgan Chase & Co. Has $7.70 Million Stock Holdings in AxoGen, Inc. (NASDAQ:AXGN) - MarketBeat

Jan 15, 2025
pulisher
Jan 15, 2025

Barclays PLC Raises Holdings in AxoGen, Inc. (NASDAQ:AXGN) - Defense World

Jan 15, 2025
pulisher
Jan 14, 2025

AxoGen, Inc. (AXGN) Soars to 52-Week High, Time to Cash Out? - MSN

Jan 14, 2025
pulisher
Jan 14, 2025

Is Axogen (NASDAQ:AXGN) Using Too Much Debt? - Simply Wall St

Jan 14, 2025
pulisher
Jan 13, 2025

Learn to Evaluate (AXGN) using the Charts - Stock Traders Daily

Jan 13, 2025

Finanzdaten der Axogen Inc-Aktie (AXGN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_devices ZBH
$105.98
price up icon 1.10%
medical_devices STE
$223.68
price up icon 1.41%
medical_devices PHG
$25.98
price up icon 1.68%
$90.75
price up icon 2.22%
$90.57
price down icon 0.57%
medical_devices EW
$72.76
price down icon 0.74%
Kapitalisierung:     |  Volumen (24h):